Alzheimer’s in the spotlight
Biocross is a biotechnology company that was created in the National Center for Biotechnology in Madrid, and recently moved to the bioincubator in Boecillo Technology Park (Valladolid). The company has suceeded in identifying key markers in blood samples that serve as...
Biocross: a multiparametric method for the blood-based diagnosis of Alzheimer’s disease
Early diagnosis a key tool in the fight against disease. It is thus essential that currently available tools are continually improved. Biocross has defined 3 main objectives that will guide the direction of this project. BioCross: Método multiparamétrico para el...
Approval of a clinical study for the identification in blood of markers.
Biocross announces approval of a clinical study for the identification in blood of markers for the diagnosis of Alzheimer’s disease using a multiparametric test – September 2011 The project, entitled “Identification of markers in blood for multiparametric...
